Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06789185Completed
Randomised trial of esketamine in emergence delirium (ED) (3 arms). Primary endpoint: The incidence of emergence delirium. Started Feb 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06789185.